The annual report should be posted by March 30th (
Post# of 11802
(Total Views: 426)
Posted On: 03/08/2018 5:10:15 PM
The annual report should be posted by March 30th (Friday) as it has been in years past. That may very well be the next release of information unless something important pops up between now and then.
Below is a timeline from the latest PR. Since all of these items are in the works, I agree, there will be a lot to say.
#January 15, 2018: global introduction of the GenSure!™ test strip.
#January 28, 2018: the company intends to finalize its testing of the
GenPrecis!™ test strip.
#February 28, 2018: the company intends to finalize its testing of the
GenPrecis!™ Precise meter.
#Late February 2018 : filing of 510K application filing for GenChoice! test
strip for market clearance with the U.S. FDA.
#March 2018 : International sales of GenChoice!™ are expected to begin.
#Private Label Updates:
"We have registered with the U.S. USPTO and the U.S. FDA two new product family names; Alltara!™ and Advant!™. These brands will become those licensed to big box retailers as their own exclusive private label. We anticipate registering more trade family names as our "big box" plan proceeds. The company is currently completing the private label packaging for the GenUltimate!™ product, now named Alltara!™ ultimate. This expansion is expected to be followed by Alltara!™ choice and then by Alltara!™ precis. First deliveries of Alltara!™ ultimate are expected in 2Q 2018. This brand will not be sold by any direct to patient distributors. First postings of product images, with disclaimers, if any, will be placed on the company's websites in coming days. The company will provide a full discussion of this business model in its 2017 Annual Report."
Below is a timeline from the latest PR. Since all of these items are in the works, I agree, there will be a lot to say.
#January 15, 2018: global introduction of the GenSure!™ test strip.
#January 28, 2018: the company intends to finalize its testing of the
GenPrecis!™ test strip.
#February 28, 2018: the company intends to finalize its testing of the
GenPrecis!™ Precise meter.
#Late February 2018 : filing of 510K application filing for GenChoice! test
strip for market clearance with the U.S. FDA.
#March 2018 : International sales of GenChoice!™ are expected to begin.
#Private Label Updates:
"We have registered with the U.S. USPTO and the U.S. FDA two new product family names; Alltara!™ and Advant!™. These brands will become those licensed to big box retailers as their own exclusive private label. We anticipate registering more trade family names as our "big box" plan proceeds. The company is currently completing the private label packaging for the GenUltimate!™ product, now named Alltara!™ ultimate. This expansion is expected to be followed by Alltara!™ choice and then by Alltara!™ precis. First deliveries of Alltara!™ ultimate are expected in 2Q 2018. This brand will not be sold by any direct to patient distributors. First postings of product images, with disclaimers, if any, will be placed on the company's websites in coming days. The company will provide a full discussion of this business model in its 2017 Annual Report."
(2)
(0)Decision Diagnostics Corp (DECN) Stock Research Links
Scroll down for more posts ▼